Pediatricians' attitudes and costs of bronchiolitis in the emergency department: A prospective multicentre study

Pediatric Pulmonology

Volumn 49, Issue 10, 2014, Pages 1011-1019

  Garcia Marcos, Luis ^a   Valverde Molina, José ^b   Pavlovic Nesic, Svetlana ^c   Claret Teruel, Gemma ^d   Peñalba Citores, Ana C ^e   Nehme Álvarez, Daniel ^f   Korta Murua, Javier ^g   Sánchez Etxaniz, Jesus ^h   Alonso Salas, Maria T ⁱ   Campos Calleja, Carmen ^j   Fernández Villar, Andrés ^k   Rodríguez Suarez, Julian ^l   Torres, Antonela Martínez ^m   Fernández, Virginia Pérez ^m  

^a Madrid Cartagena S n   (Spain)

^b Hospital Los Arcos Del Mar Menor   (Spain)

^c Canarias Children's Hospital   (Spain)

^d Sant Joan de Deu   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^f HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^g HOSPITAL DONOSTIA   (Spain)

^h HOSPITAL DE CRUCES   (Spain)

ⁱ HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^j HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^k HOSPITAL DE CABUEÑES   (Spain)

^l Asturias Central University Hospital   (Spain)

^m HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

more..

Author keywords

Bronchiolitis; Costs; Emergency department; Syncytial respiratory virus; Wheezing

Indexed keywords

ARTICLE; BRONCHIOLITIS; CHILD; COMPARATIVE STUDY; COST OF ILLNESS; DISEASE SEVERITY; EMERGENCY WARD; EUROPE; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; PEDIATRICIAN; PHYSICIAN ATTITUDE; PRESCHOOL CHILD; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SAMPLE SIZE; SPAIN; TERTIARY CARE CENTER; ABSENTEEISM; CLINICAL TRIAL; DIAGNOSTIC TEST; ECONOMICS; EMERGENCY HEALTH SERVICE; HEALTH PERSONNEL ATTITUDE; INFANT; MEAL; MULTICENTER STUDY; PEDIATRICS; PROSPECTIVE STUDY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; SEVERITY OF ILLNESS INDEX; TRAVEL;

ABSENTEEISM; ATTITUDE OF HEALTH PERSONNEL; BRONCHIOLITIS; DIAGNOSTIC TESTS, ROUTINE; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INFANT; MALE; MEALS; PEDIATRICS; PROSPECTIVE STUDIES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; SEVERITY OF ILLNESS INDEX; SPAIN; TRAVEL;

EID: 84908219642     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.22906     Document Type: Article

References (36)

1. Subcommittee on Diagnosis and Management of Bronchiolitis. American Academy of Pediatrics. Diagnosis and management of bronchiolitis. Pediatrics 2006;118:1774-1793.
2. McConnochie KM. Bronchiolitis. What's in the name? Am J Dis Child 1983;137:11-13.
3. Mallol J, Garcia-Marcos L, Sole D, Brand P. International prevalence of recurrent wheezing during the first year of life: variability, treatment patterns and use of health resources. Thorax 2010;65:1004-1009.
4. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999;282:1440-1446.
5. Diez DJ, Ridao LM, Ubeda Sansano I, Ballester SA. [Incidence and cost of hospitalizations for bronchiolitis and respiratory syncytial virus infections in the autonomous community of Valencia in Spain (2001 and 2002)]. An Pediatr (Barc) 2006;65: 325-330.
6. Jennings LC, Anderson TP, Werno AM, Beynon KA, Murdoch DR. Viral etiology of acute respiratory tract infections in children presenting to hospital: role of polymerase chain reaction and demonstration of multiple infections. Pediatr Infect Dis J 2004; 23:1003-1007.
7. Legg JP, Warner JA, Johnston SL, Warner JO. Frequency of detection of picornaviruses and seven other respiratory pathogens in infants. Pediatr Infect Dis J 2005;24:611-616.
8. Ma X, Endo R, Ishiguro N, Ebihara T, Ishiko H, Ariga T, Kikuta H. Detection of human bocavirus in Japanese children with lower respiratory tract infections. J Clin Microbiol 2006;44:1132-1134.
9. Garcia-Garcia ML, Calvo C, Perez-Brena P, De Cea JM, Acosta B, Casas I. Prevalence and clinical characteristics of human metapneumovirus infections in hospitalized infants in Spain. Pediatr Pulmonol 2006;41:863-871.
10. Garcia-Garcia ML, Calvo C, Falcon A, Pozo F, Perez-Brena P, De Cea JM, Casas I. Role of emerging respiratory viruses in children with severe acute wheezing. Pediatr Pulmonol 2010;45:585-591.
11. Pientong C, Ekalaksananan T, Teeratakulpisarn J, Tanuwattanachai S, Kongyingyoes B, Limwattananon C. Atypical bacterial pathogen infection in children with acute bronchiolitis in northeast Thailand. J Microbiol Immunol Infect 2011;44:95-100.
12. Korppi M, Hiltunen J. Pertussis is common in nonvaccinated infants hospitalized for respiratory syncytial virus infection. Pediatr Infect Dis J 2007;26:316-318.
13. Robinson RF. Impact of respiratory syncytial virus in the United States. Am J Health Syst Pharm 2008;65:S3-S6.
14. Creery D, Lyer P, Samson L, Coyle D, Osborne G, MacDonald A. Costs associated with infant bronchiolitis in the Baffin region of Nunavut. Int J Circumpolar Health 2005;64:38-45.
15. Lofland JH, O'Connor JP, Chatterton ML, Moxey ED, Paddock LE, Nash DB, Desai SA. Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: a cost-effectiveness analysis. Clin Ther 2000;22:1357-1369.
16. Pelletier AJ, Mansbach JM, Camargo CA, Jr. Direct medical costs of bronchiolitis hospitalizations in the United States. Pediatrics 2006;118:2418-2423.
17. Langley JM,Wang EE, Law BJ, Stephens D, Boucher FD, Dobson S, McDonald J, MacDonald NE, Mitchell I, Robinson JL. Economic evaluation of respiratory syncytial virus infection in Canadian children: a Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study. J Pediatr 1997;131:113-117.
18. Stang P, Brandenburg N, Carter B. The economic burden of respiratory syncytial virus-associated bronchiolitis hospitalizations. Arch Pediatr Adolesc Med 2001;155:95-96.
19. Paramore LC, Ciuryla V, Ciesla G, Liu L. Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases. Pharmacoeconomics 2004;22:275-284.
20. Lee JT, Chang LY, Wang LC, Kao CL, Shao PL, Lu CY, Lee PI, Chen JM, Lee CY, Huang LM. Epidemiology of respiratory syncytial virus infection in northern Taiwan, 2001-2005-seasonality, clinical characteristics, and disease burden. J Microbiol Immunol Infect 2007;40:293-301.
21. Shi N, Palmer L, Chu BC, Katkin JP, Hall CB, Masaquel AS, Mahadevia PJ. Association of RSV lower respiratory tract infection and subsequent healthcare use and costs: a Medicaid claims analysis in early-preterm, late-preterm, and full-term infants. J Med Econ 2011;14:335-340.
22. Farina D, Rodriguez SP, Bauer G, Novali L, Bouzas L, Gonzalez H, Gilli C, Laffaire E. Respiratory syncytial virus prophylaxis: cost-effective analysis in Argentina. Pediatr Infect Dis J 2002;21: 287-291.
23. Vogel AM, McKinlay MJ, Ashton T, Lennon DR, Harding JE, Pinnock R, Graham D, Grimwood K, Pattemore PK, Schousboe M. Cost-effectiveness of palivizumab in New Zealand. J Paediatr Child Health 2002;38:352-357.
24. Wegner S, Vann JJ, Liu G, Byrns P, Cypra C, Campbell W, Stiles A. Direct cost analyses of palivizumab treatment in a cohort of atrisk children: evidence from the North Carolina Medicaid Program. Pediatrics 2004;114:1612-1619.
25. Zaw W, McDonald J. Respiratory syncytial virus bronchiolitis in ex-preterm infants in the Scottish highlands: review of hospital admissions and an analysis of hospital cost. Scott Med J 2003; 48:108-110.
26. Yong JH, Schuh S, Rashidi R, Vanderby S, Lau R, Laporte A, Nauenberg E, Ungar WJ. A cost effectiveness analysis of omitting radiography in diagnosis of acute bronchiolitis. Pediatr Pulmonol 2009;44:122-127.
27. Domingo SA, Marcos AJ. [Proposal of an indicator of social class based on the occupation]. Gac Sanit 1989;3:320-326.
28. Wood DW, Downes JJ, Lecks HI. A clinical scoring system for the diagnosis of respiratory failure. Preliminary report on childhood status asthmaticus. Am J Dis Child 1972;123:227-228.
29. Ferres J, Llacer MJ, Solis E, Salmeron M, Andreu T, Zorrilla T, Julia A. Comparative study of salbutamol versus procaterol in the treatment of acute bronchospasm in children. Curr Ther Res Clin Exp 1993;53:215-221.
30. Martinez-Moragon E, Serra-Batlles J, De Diego A, Palop M, Casan P, Rubio-Terres C, Pellicer C. Economic cost of treating the patient with asthma in Spain: the AsmaCost study. Arch Bronconeumol 2009;45:481-486.
31. Martinon-Torres F, Bouzon-Alejandro M, Lopez-Sousa M, Redondo-Collazo L, Almeida-Agudin S, Astorgano-Fernandez C, Martinon-Sanchez JM. An estimation of indirect costs caused by acute rotavirus gastroenteritis in a Galician area, Spain. Eur J Pediatr 2008;167:337-339.
32. The IMpact-RSV Study Group. Palivizumab a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998;102:531-537.
33. Bordley WC, Viswanathan M, King VJ, Sutton SF, Jackman AM, Sterling L, Lohr KN. Diagnosis and testing in bronchiolitis: a systematic review. Arch Pediatr Adolesc Med 2004;158:119-126.
34. Lozano JM, Wang E. Bronchiolitis. Clin Evid 2002;7:272-282.
35. Hartling L, Bialy LM, Vandermeer B, Tjosvold L, Johnson DW, Plint AC, Klassen TP, Patel H, Fernandes RM. Epinephrine for bronchiolitis. Cochrane Database Syst Rev 2011;7:CD0031236.
36. Plint AC, Johnson DW, Wiebe N, Bulloch B, Pusic M, Joubert G, Pianosi P, Turner T, Thompson G, Klassen TP. Practice variation among pediatric emergency departments in the treatment of bronchiolitis. Acad Emerg Med 2004;11:353-360.